S2: #016: Harry Rowland on Touching Hearts with Implantable Technology - a podcast by Dan Kendall / Part of the Health Podcast Network
from 2021-01-31T22:10:42.023393
Today I’m talking with Harry Rowland, co-founder and CEO of Endotronix. Endotronix was founded in 2007 and is developing an implantable pressure sensor that can be placed in the pulmonary artery outside the heart.
Dr. Rowland has led the company’s innovation, strategy and technology developments since the project began and has raised millions of dollars in funding. In this episode, he shares the exciting new prospects this technology offers as part of a complete health system that provides tools and feedbacks to help extend and improve patient’s lives.
Today’s Topics:
Dr. Rowland’s background in engineering and healthcare entrepreneurship
Advanced heart failure, current standards of care and healthcare costs
Endotronix implantable sensors and proactive heart disease management
Raising capital for the business
Perseverance and commitment as a startup
Future of Endotronix and clinical testing
Advice for new healthcare startups
Engaging both patients and clinicians to make the product successful
Links and Resources Mentioned:
Digital Health Events
Dan Kendall @ Twitter
Dan@digitalhealth.com
Join Digital Health Today
Endotronix website
Endotronix Wireless Health Monitoring video
Win Forever by Pete Carroll
Heart Failure Society of America
European Society of Cardiology – Heart Failure Association
Learn more about your ad choices. Visit megaphone.fm/adchoices
Further episodes of Digital Health Today 360 with Dan Kendall
Further podcasts by Dan Kendall / Part of the Health Podcast Network